High-level expression of modified gene encoding human adiponectin in transgenic rice

Area of Science:

• Biotechnology
• Molecular Biology
• Plant Science

Background:

• Adiponectin deficiency is linked to obesity and type II diabetes.
• Pharmaceutical applications require large-scale production of human adiponectin.
• Transgenic approaches offer a potential solution for recombinant protein production.

Purpose of the Study:

• To develop a method for high-level expression of human adiponectin in transgenic rice.
• To optimize gene constructs for enhanced protein yield in a plant system.
• To confirm the successful production and accumulation of functional recombinant adiponectin.

Main Methods:

• Modification of human adiponectin cDNA for rice codon usage and inclusion of regulatory sequences (translation initiation, KDEL signal, transcription enhancer).
• Generation of transgenic rice plants harboring the modified adiponectin gene.
• Molecular analysis including PCR, Southern blot, and RT-PCR to confirm transgene integration and transcription.
• Protein analysis using Western blot and ELISA to detect and quantify recombinant adiponectin expression in rice leaves.

Main Results:

• Successful integration and transcription of the modified human adiponectin gene in transgenic rice.
• Detection of a recombinant protein of approximately 30 kDa in rice leaves via Western blot.
• Quantification of recombinant adiponectin representing up to 0.32% of total soluble leaf protein using ELISA.
• Demonstration of high-level expression of recombinant human adiponectin in a plant-based system.

Conclusions:

• Transgenic rice can be effectively engineered for high-level production of recombinant human adiponectin.
• This study validates the feasibility of using rice as a bioreactor for pharmaceutical protein manufacturing.
• The developed system holds promise for addressing the demand for adiponectin in treating metabolic disorders.